High Altitude/Diving Adaptations Flashcards
1
Q
Method of calculation of inspired O2, PAO2, and the A-a gradient
A
- PAO2 = (Pb – PH20) x FiO2 – (PaCO2 / R)
- Pb = barometric pressure
- R=~0.8 (generally)
- barometric pressure decreases (at high altitude) ==> PaO2 decreases ==> ventilation increases (PaCO2 decreases) to compensate
- A-a = PAO2 - PaO2
- PaO2 = arterial O2 content
2
Q
Acute cardiac adaptations to high altitude
A
- Increased CO
- HR increases within minutes of hypoxia exposure (sympathetic response)
SV increases as a result of systemic vasodilation, which decreases afterload
- Acute adaptive response only – returns to normal within days
3
Q
Acute ventilatory adaptations to high altitude
A
- Increased minute ventilation (VE)
- hypoxemia ==> hyperventilate ==> increased PaO2 (& decreased in PaCO2) & increased Hb saturation
- can last days-weeks & is most useful short-term adaptation
4
Q
Acetazolamide characteristics/fxn
A
- Oral diuretic
- acetazolamide causes a metabolic acidosis through renal bicarbonate loss
- acidosis triggers a reflexive increase in VE to lower PaCO2 and thus incrase pH back toward normal and via the law of partial pressures a parallel increase in PaO2 follows
5
Q
Chronic adaptations to high altitude (general)
A
- increased Hb content & saturation
- exaggerated ventilator response
- skelatal muscle adaptations
- vascular adaptations
6
Q
Hb adaptations to high altitude
A
- Increased Hb content
- Via EPO secreted from the kidneys – occurs over weeks
- Overall effect is to increase Hb and red cell mass
- Increased hematocrit with decreased plasma volume
- Increased Hb saturation
- Structural changes in Hb that alter its affinity for O2
- A “left shift” in the O2-Hb curve occurs due to respiratory alkalosis (hyperventilation/decreased PaCO2) which increases O2 saturation of Hb at any given PaO2
7
Q
Ventilator response adaptation to high altitude
A
- Acclimatized individuals have increased VE at a given PAO2 compared to the VE of a person just arrived at the same altitude; this decreases PACO2 and allows PaO2 levels to remain up
- Hypoxic ventilator responses are triggered at higher PaO2 (63 mmHg) in acclimatized individuals vs. in un-acclimatized (55mmHg)
- Due to altered gene expression/altered “set points” for PaCO2 and PaO2
8
Q
Major illnesses associated w/high altitude exposure
A
- Acute mountain sickness (AMS)
- High altitude cerebral edema (HACE)
- High altitude pulmonary edema (HAPE)
- Chronic mountain sickness
9
Q
Characteristics of AMS
A
- Mildest but most common form of acute altitude illness
- Headache, nausea, malaise, insomnia, anorexia
- rare < 6,000 ft but increases to 25% at altitudes 9-10,000 ft
- Symptoms start after 6 hours at altitude and peak by 1 day
- Quick ascent increases AMS risk
- Mechanism: increase in brain volume in response to hypoxia, caused by vasogenic cerebral edema and/or increased cerebral blood flow (“tight box”)
10
Q
AMS tx and prevention
A
- Treatment: Sx usually resolve without treatment
- treatment with oral dexamethasone (corticosteroid) [blunts hypoxic induction of brain vessel permeability-inducing proteins] OR
- oral acetazolamide (diuretic causing metabolic acidosis and compensatory hyperventilation) will hasten resolution of AMS symptoms
- Prevention:
- either dexamethasone or acetazolamide may be used to prevent
- ibuprofen to prevent headache
11
Q
HACE sx & tx
A
- HACE = extreme form of AMS – medical emergency!
- Mechanism: same as AMS but more severe
- Early symptoms are similar to AMS but progressively worsen to include confusion, hallucinations, and coma
- Treatment is supportive (oxygen, descent) followed by IV dexamethasone
12
Q
HAPE sx, signs, mechanism
A
- onset is usually on the 2nd day
- Sx: cough (occasionally pink frothy sputum), SOB, fatigue +/- signs and symptoms of AMS
- Signs: hypoxia, lung rales, infiltrates on CXR
- Mechanism: non-cardiogenic pulmonary edema (LA pressures normal, diuretics don’t help) associated with pulmonary hypertension in response to acute hypoxia
- Occurs in people who are more prone to accentuated hypoxic PHTN
13
Q
HAPE tx & prevention
A
- Treatment: descent, supplemental oxygen, vasodilator medications to lower pulmonary artery pressure (Nifedipine [CCB])
- Prevention:
- Pulmonary vasodilators (Nifedipine)
- Dexamethasone
- Salmeterol (a long acting beta-agonist bronchodilator that increases the clearance rate of water out of alveoli by increasing activity of Na-K ATPase)
14
Q
Chronic mountain sickness characteristics
A
- Occurs in people who live at high mountain altitudes > 10,000 ft but are not genetically adapted (i.e. Han Chinese living in Tibet
- Polycythemia and PHTN = Chronic Mountain Sickness (CMS)
- Increased risk of stroke and heart failure
- Treatment: move to lower altitude, supplemental O2, phlebotomy
- w/severe hypoxia, the concentration gradient for oxygen (the difference in PO2 between mixed venous blood and alveolar PO2) is lessened, leading to diffusion limitation for oxygen
15
Q
General characteristics of breathing at depth (underwater)
A
- increased barometric pressure below sea level ==> exerts pressure on airways/organs
- increased airway pressure ==> increased density of air gas ==> increased resistive work of breathing
- “squeeze” ==> decreased lung volumes
- divers breathing pressurized gas avoid this problem
- increased venous return ==> increased CO & central filling pressure